#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperinsulinaemic hypoglycaemia Renal cancer metastatic Follicular lymphoma stage II Myasthenia gravis Autologous haematopoietic stem cell transplant Dementia with Lewy bodies Mycobacterium abscessus infection Essential thrombocythaemia Breast cancer metastatic Anti-neutrophil cytoplasmic antibody positive vasculitis Cholangiocarcinoma Haemophilia B without inhibitors Infertility male Progressive supranuclear palsy Oropharyngeal cancer recurrent More trials…

    Learn about Rare Diseases

    Idiopathic inflammatory myopathy – Treatment Glycogen storage disease type V – Basic Information Factor VIII deficiency – Basic Information Mantle cell lymphoma stage IV – Treatment Crigler-Najjar syndrome – Basic Information Breast angiosarcoma – Diagnostics Ewing’s sarcoma recurrent – Treatment Breast angiosarcoma metastatic – Treatment Primary hyperoxaluria Urea cycle disorder – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Thymalfasin Ly3437943 Sodium Phenylalanine Elranatamab Irbesartan Xtmab-16 Roxadustat Colchicine Valoctocogene Roxaparvovec Bi 764524 PETHIDINE HYDROCHLORIDE 1,3-BUTYLENE GLYCOL Citalopram Hydrochloride Gallium (68Ga) Chloride Enpatoran Pegipanermin Palbociclib HYDROMORPHONE HYDROCHLORIDE Alirocumab Ranibizumab More therapies…

    Learn about Your Condition

    Renal transplant Viral myocarditis Naevus flammeus Round cell liposarcoma Pleomorphic liposarcoma Ewing's sarcoma Breast cancer stage IV Peripheral artery stenosis EGFR gene mutation Epiphysiolysis Corticobasal degeneration Compulsive sexual behaviour Giant cell arteritis Aortic disorder Breast cancer stage III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Glioma

  • A study of ulixertinib, tovorafenib, and vinblastine sulfate for children with progressive, relapsed, or refractory low-grade glioma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Tovorafenib
    • Vinblastine Sulfate
    • ULIXERTINIB
    Austria Czechia Denmark Germany Sweden

  • Study on Bevacizumab and Dexamethasone for Treating Brain Radiation Damage in Patients with High-Grade Glioma or Brain Metastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Bevacizumab
    The Netherlands

  • Study of Temozolomide and Lomustine Followed by Radiotherapy versus Standard Treatment in Patients with Newly Diagnosed Grade 2 or 3 Glioma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Lomustine
    • Procarbazine
    • Temozolomide
    Germany

  • Study Comparing Trametinib and Vinblastine for Children and Young Adults with Newly Diagnosed Low-Grade Glioma with Wild-Type BRAF Gene

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Vinblastine Sulfate
    • Trametinib
    France

  • Study of Larotrectinib and Drug Combination for Children with Newly Diagnosed High-Grade Glioma with NTRK Fusion

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Larotrectinib Sulfate
    • Etoposide Phosphate
    • Cyclophosphamide Monohydrate
    Germany

  • Study on Fluorodopa (18F) for Diagnosing Low-Grade Glioma in Patients Without MRI Contrast Enhancement

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Fluorodopa (18F)
    France
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!